The breakthrough could simplify the production of complex proteins used in cancer immunotherapy and other advanced medicines ...

Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...

Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound. This method opens up new possibilities for the synthesis of tailored protein ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists. Initially approved by the FDA for the treatment of type 2 diabetes, ...

Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...

TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

The primary feature of biosurfactants is their ability to considerably minimize surface and interfacial stress in between immiscible phases, such as oil and water, facilitating the development of ...